Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

The rise of misinformation online has helped fringe health ideas go mainstream and eased RFK Jr.'s path to confirmation as ...

Co's stock has reached a 52-week low, dipping to $85.71. This downturn reflects a significant shift from the previous year, with the pharmaceutical giant experiencing a 1-year change of -31.59%.

We recently published an article titled Why These 10 Dividend Stocks Are Declining? In this article, we are going to take a ...

Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...

Companies that pay dividends have been a reliable choice for investors seeking a passive and somewhat stable income.

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Tuesday, the agency signed off on SpringWorks’ Gomekli (mirdametinib) as a treatment for the rare genetic disorder ...

Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.